Understanding how well patients tolerate and adhere to oral antibiotics for bone and joint infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with osteoarticular infections who are undergoing treatment with oral antibiotics for at least six weeks. It aims to assess the tolerance and adherence to antibiotic therapy, which is crucial given the potential for severe adverse effects and the complexity of treatment regimens. By monitoring patients' experiences, the study seeks to identify factors that influence compliance and the overall impact on treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥ 18 years
* Diagnosis of osteoarticular infection
* Treatment with at least one oral antibiotic for a minimum expected duration ≥ 6 weeks with an expected end of treatment date
* Patient who was informed and did not object to participate in the study

Exclusion Criteria:

* Treatment for BJI with oral antibiotic without end of treatment date
* treatment for BJI with parenteral antibiotic only
* patient who doesn't have a telephone number or who doesn't want to give it
* Adults subject to a legal protection measure
* Pregnant or breastfeeding women

Where it's running

• Hospices Civils de Lyon
  Lyon, France Recruiting

Study contacts

• Principal investigator: Valérie MIRABET — Hospices Civils de Lyon
• Study coordinator: Tristan FERRY, MD, PHD
• Email: tristan.ferry@chu-lyon.fr
• Phone: 4 26 73 29 38

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UGT1A1 gene and side effects from certain antibody-drug treatments for advanced breast cancer

  This project will test whether common UGT1A1 gene variants explain who gets worse side effects from antibody-drug conjugates (sacituzumab-govitecan, trastuzumab-deruxtecan, or datopotamab-deruxtecan) in adults with advanced breast cancer.

  Recruiting Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · Granada, Granada · NCT07582887

• Flexible online mindfulness program for pediatric residents

  This program will test whether letting pediatric residents choose a 3-, 5-, or 7-week online mindfulness course improves engagement, satisfaction, and completion compared with being assigned a length.

  Recruiting Northwestern University · Chicago, Illinois · NCT07542769

• Telenursing to detect and manage side effects from CDK4/6 inhibitors in breast cancer

  This project tests whether scheduled phone or video contacts from trained nurses, added to usual care, help people with breast cancer taking CDK4/6 inhibitors notice and manage side effects earlier and stay on treatment.

  Recruiting Azienda Sanitaria Locale di Asti · Asti, ASTI · NCT07524829

• IMMUNO-FIT: How immunotherapy affects fitness and quality of life in adults with solid cancers

  We will see if starting immunotherapy changes physical fitness, quality of life, and how well adults with solid cancers tolerate treatment.

  Recruiting University Hospital Southampton NHS Foundation Trust · Southampton, Hampshire · NCT07354971

• Fecal transplant for chemotherapy and targeted-therapy gut side effects in advanced gastrointestinal cancer

  This trial will try oral fecal microbiota transplants (FMT) to see if they reduce chemotherapy or targeted-therapy–related gut symptoms in adults with advanced gastrointestinal cancers.

  Recruiting Phase 1 Second Affiliated Hospital, Zhejiang University, School of Medicine · Zhejiang, Hangzhou · NCT07319364

• LY3537021 for preventing chemo-related nausea and vomiting in adults

  This trial will test whether adding LY3537021 to standard anti-nausea care helps prevent nausea and vomiting in adults starting AC or high-dose cisplatin chemotherapy.

  Recruiting at 58 sites Phase 2 Eli Lilly and Company · Greenbrae, California and 66 other locations · NCT07169851

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.